Physician profile
Alex Birman
NPI 1598964694
$974.00
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $300 · 2021: $121 · 2022: $61.81 · 2023: $86.18 · 2024: $64.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $470.14 | 2019-2023 | Lo Loestrin Fe |
| Medical Device Business Services, INC. | $118.34 | 2019 | |
| Allergan, INC. | $85.71 | 2019-2021 | |
| Agile Therapeutics, INC. | $58.90 | 2021-2023 | Twirla |
| Therapeuticsmd, INC. | $52.46 | 2021 | |
| Mylan Pharmaceuticals INC. | $48.61 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $37.53 | 2023 | |
| Coopersurgical, INC. | $35.54 | 2022-2024 | Paragard T 380a |
| Roche Diagnostics Corporation | $23.93 | 2019 | |
| Hologic Sales and Service, LLC | $22.16 | 2024 | Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $20.68 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Birman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.